(Q44696092)

5 December 2017

title

The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators (English)

1 reference

5 December 2017

0 references

1 reference

1

P E Marik

1 reference

5 December 2017

G P Zaloga

2

1 reference

5 December 2017

NORASEPT II Study Investigators. North American Sepsis Trial II

series ordinal

3

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Journal of the American Geriatrics Society

5 December 2017

published in

1 reference

5 December 2017

volume

49

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

5-9

1 reference

Trends in Infectious Disease Hospitalizations in the United States, 1980-1994

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Shock and tissue injury induced by recombinant human cachectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Adjunctive therapy for septic shock: a review of experimental approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Experimental therapies for sepsis directed against tumour necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Issues in the adjunct therapy of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

21 January 2018

New therapies in sepsis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Cytokine production pathway in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Serum IL-6 level and the development of disability in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Afebrile bacteremia. A phenomenon in geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

The pathophysiologic roles of interleukin-6 in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

The cell biology of aging: immunological models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

The pituitary-adrenal glucocorticoid response is altered by gender and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Relation of age to left ventricular function in clinically normal adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Heart failure associated with preserved systolic function: a common and costly clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Time course of cytokine levels in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Interleukin-10: biology, role in inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Interleukin 10 protects mice from lethal endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Hypothesis: compartmentalization of cytokines in intraabdominal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

Elderly Humans Show Prolonged In Vivo Inflammatory Activity during Pneumococcal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2001.49003.X

10.1046/J.1532-5415.2001.49003.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference